Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and 2.2.2-Cryptand: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 456619557 of page 2.2.2-Cryptand for the Chem/Drugbox validation project (updated: ''). |
no longer a stub |
||
Line 1: | Line 1: | ||
{{correct title|[2.2.2]Cryptand|reason=bracket|edit=omission}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:2.2.2-Cryptand|oldid=456619557}} 456619557] of page [[2.2.2-Cryptand]] with values updated to verified values.}} |
|||
{{Chembox |
{{Chembox |
||
⚫ | |||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
| ImageFile_Ref = {{chemboximage|correct|??}} |
|||
| ImageFile = Cryptand.svg |
|||
⚫ | |||
| ImageName = Skeletal formula of 2.2.2-cryptand |
| ImageName = Skeletal formula of 2.2.2-cryptand |
||
⚫ | |||
| SystematicName = 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane<ref>{{Cite web|url = http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=72801|title = cryptating agent 222 - PubChem Public Chemical Database|work = The PubChem Project|location = USA|publisher = National Center for Biotechnology Information|at = Descriptors Computed from Structure}}</ref> |
|||
| ImageFile1 = 2.2.2-Cryptand-3D-balls-by-AHRLS-2012.png |
|||
| OtherNames = Cryptating agent 222{{Citation needed|date = June 2011}} |
|||
| ImageSize1 = 150 |
|||
⚫ | |||
| ImageFileL2 = 2.2.2-Cryptand-3D-sticks-by-AHRLS-2012.png |
|||
| Abbreviations = Crypt-222 |
|||
| ImageSizeL2 = 140 |
|||
⚫ | |||
| ImageFileR2 = 2.2.2-Cryptand-3D-vdW-by-AHRLS-2012.png |
|||
⚫ | |||
| |
| ImageSizeR2 = 140 |
||
| PIN = 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane |
|||
| PubChem_Ref = {{Pubchemcite|correct|pubchem}} |
|||
| OtherNames = Cryptating agent 222<ref>In the Nomenclature of Inorganic Chemistry (2005), IUPAC recommends the abbreviation crypt-222.</ref> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| |
| Abbreviations = Crypt-222 |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
⚫ | |||
| UNII = 18V22YHN6G |
|||
⚫ | |||
| PubChem = 72801 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| EINECS = 245-962-4 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
| |
|Section2={{Chembox Properties |
||
| |
| Formula = {{Chem|C|18|N|2|H|36|O|6}} |
||
| |
| MolarMass = 376.4882 g mol<sup>−1</sup> |
||
| MeltingPtC = 68 to 71 |
|||
| ExactMass = 376.257336894 g mol<sup>-1</sup> |
|||
| MeltingPtCL = 68 |
|||
| MeltingPtCH = 71 |
|||
}} |
}} |
||
| |
|Section3={{Chembox Hazards |
||
| |
| GHSPictograms = {{GHS exclamation mark}} |
||
| |
| GHSSignalWord = '''WARNING''' |
||
| |
| HPhrases = {{H-phrases|315|319|335}} |
||
| |
| PPhrases = {{P-phrases|261|305+351+338}} |
||
| EUClass = {{Hazchem Xi}} |
|||
| RPhrases = {{R36/37/38}} |
|||
| SPhrases = {{S26}}, {{S36}} |
|||
}} |
}} |
||
}} |
}} |
||
'''[2.2.2]Cryptand''' is the [[organic compound]] with the formula N(CH<sub>2</sub>CH<sub>2</sub>OCH<sub>2</sub>CH<sub>2</sub>OCH<sub>2</sub>CH<sub>2</sub>)<sub>3</sub>N. This [[Cyclic molecule|bicyclic]] molecule is the most studied member of the [[cryptand]] family of [[chelating agent]]s.<ref>{{cite journal|last1=Kang|first1=Sung Ok|last2=Llinares|first2=José M.|last3=Day|first3=Victor W.|last4=Bowman-James|first4=Kristin|author-link4=Kristin Bowman-James|year=2010|title=Cryptand-like anion receptors|journal=Chemical Society Reviews|volume=39|issue=10|pages=3980–4003|doi=10.1039/C0CS00083C|pmid=20820597}}</ref> It is a white solid. Many analogous compounds are known. Their high affinity for [[alkali metal]] cations illustrates the advantages of "preorganization", a concept within the area of [[supramolecular chemistry]]. |
|||
For the design and synthesis of [2.2.2]cryptand,<ref>{{cite journal |doi=10.1016/S0040-4039(01)88300-3|title=Les Cryptates|year=1969|last1=Dietrich|first1=B.|last2=Lehn|first2=J.M.|last3=Sauvage|first3=J.P.|journal=Tetrahedron Letters|volume=10|issue=34|pages=2889–2892}}</ref> [[Jean-Marie Lehn]] shared the [[Nobel Prize in Chemistry]]. The compound was originally prepared starting with the diacylation of the diamine-diether:<ref>{{cite journal |doi=10.1016/S0040-4039(01)88299-X|title=Diaza-polyoxa-macrocycles et macrobicycles|year=1969|last1=Dietrich|first1=B.|last2=Lehn|first2=J.M.|last3=Sauvage|first3=J.P.|journal=Tetrahedron Letters|volume=10|issue=34|pages=2885–2888}}</ref> |
|||
:[CH<sub>2</sub>OCH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>]<sub>2</sub> + [CH<sub>2</sub>OCH<sub>2</sub>COCl]<sub>2</sub> → [CH<sub>2</sub>OCH<sub>2</sub>CH<sub>2</sub>NHC(O)CH<sub>2</sub>]<sub>2</sub> + 2 HCl |
|||
The resulting [[Macrocycle|macrocyclic]] diamide is reduced by [[lithium aluminium hydride]]. The resulting macrocyclic diamine tetraether reacts with a second equivalent of [CH<sub>2</sub>OCH<sub>2</sub>COCl]<sub>2</sub> to produce the macro''bi''cyclic diamide. This di(tertiary)amide is reduced to the diamine by [[diborane]]. |
|||
[2.2.2]Cryptand binds [[potassium|K<sup>+</sup>]] as an [[Denticity|octadentate]] N<sub>2</sub>O<sub>6</sub> ligand. The resulting cation K([2.2.2]cryptand)<sup>+</sup> is lipophilic. |
|||
[[Image:Cryptate of potassium cation.jpg|thumbnail|left|Structure of [2.2.2]cryptand encapsulating a [[potassium]] cation (purple) as determined by [[X-ray crystallography]]<ref>{{cite journal |author1=Alberto, R. |author2=Ortner, K. |author3=Wheatley, N. |author4=Schibli, R. |author5=Schubiger, A. P. | title = Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [<sup>99m</sup>Tc(OH<sub>2</sub>)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> | journal = [[J. Am. Chem. Soc.]] | year = 2001 | volume = 121 | pages = 3135–3136 | doi = 10.1021/ja003932b |pmid=11457025 | issue = 13}}</ref>]]{{clear-left}} |
|||
==References== |
|||
{{Reflist}} |
|||
{{DEFAULTSORT:Cryptand, 2.2.2-}} |
|||
[[Category:Chelating agents]] |